# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001023024-24-000037
Filing Date
2024-04-05
Accepted
2024-04-05 16:04:34
Documents
27
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | anip-20240405.htm iXBRL | DEF 14A | 1273068
6 |  | anip-20240405_g1.jpg | GRAPHIC | 61789
7 |  | anip-20240405_g10.jpg | GRAPHIC | 81198
8 |  | anip-20240405_g11.jpg | GRAPHIC | 76616
9 |  | anip-20240405_g12.jpg | GRAPHIC | 847871
10 |  | anip-20240405_g13.jpg | GRAPHIC | 214846
11 |  | anip-20240405_g2.jpg | GRAPHIC | 37141
12 |  | anip-20240405_g3.jpg | GRAPHIC | 18458
13 |  | anip-20240405_g4.jpg | GRAPHIC | 244294
14 |  | anip-20240405_g5.jpg | GRAPHIC | 95546
15 |  | anip-20240405_g6.jpg | GRAPHIC | 2547
16 |  | anip-20240405_g7.jpg | GRAPHIC | 2297
17 |  | anip-20240405_g8.jpg | GRAPHIC | 2598
18 |  | anip-20240405_g9.jpg | GRAPHIC | 2403
| Complete submission text file | 0001023024-24-000037.txt |  | 6170457

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | anip-20240405.xsd | EX-101.SCH | 4141
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | anip-20240405_def.xml | EX-101.DEF | 6377
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | anip-20240405_lab.xml | EX-101.LAB | 7898
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | anip-20240405_pre.xml | EX-101.PRE | 5012
30 | EXTRACTED XBRL INSTANCE DOCUMENT | anip-20240405_htm.xml | XML | 277669

Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 24826440
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)